Patents by Inventor Francois Bernier

Francois Bernier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180024150
    Abstract: Cholesterol and desmosterol levels, and the ratio of these levels can be used as a blood biomarker for Alzheimer's disease, frontotemporal lobar degeneration, or dementia with Lewy bodies.
    Type: Application
    Filed: March 4, 2016
    Publication date: January 25, 2018
    Inventors: Takeshi IKEUCHI, Ryozo KUWANO, Yoshiaki SATO, Francois BERNIER
  • Patent number: 9581604
    Abstract: Desmosterol alone, the combination of desmosterol and amyloid beta, the combination of desmosterol and gelsolin and the combination of desmosterol, amyloid beta and gelsolin can be used as in-blood biomarkers for Alzheimer's disease or mild cognitive impairment. A method for evaluating the effect of a candidate for a therapeutic agent to treat Alzheimer's disease or mild cognitive impairment, a method for aiding the diagnosis of Alzheimer's disease or mild cognitive impairment, and a method for diagnosing Alzheimer's disease or mild cognitive impairment are provided in which the biomarkers are used.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: February 28, 2017
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Yoshiaki Sato, Ken Aoshima, Francois Bernier
  • Publication number: 20130266589
    Abstract: Desmosterol alone, the combination of desmosterol and amyloid beta, the combination of desmosterol and gelsolin and the combination of desmosterol, amyloid beta and gelsolin can be used as in-blood biomarkers for Alzheimer's disease or mild cognitive impairment. A method for evaluating the effect of a candidate for a therapeutic agent to treat Alzheimer's disease or mild cognitive impairment, a method for aiding the diagnosis of Alzheimer's disease or mild cognitive impairment, and a method for diagnosing Alzheimer's disease or mild cognitive impairment are provided in which the biomarkers are used.
    Type: Application
    Filed: June 23, 2011
    Publication date: October 10, 2013
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Yoshiaki Sato, Ken Aoshima, Francois Bernier
  • Publication number: 20110041572
    Abstract: The invention relates to a method of manufacturing locks for doors of a plurality of models of motor vehicles, each lock comprising a latch (1) which is rotatable about an axis (A) and which is associated with a pawl (2) rotatable about an axis (B), and also a mechanical and/or electrical transmission arrangement for carrying out an identical list of commands, the positioning of the fastening points (3, 4, 5) of these locks being identical, and the relative positioning of their “S point” (S1, S2) being different. According to the invention, said mechanical and/or electrical transmission arrangement of each of the locks is identical and only the assembly consisting of the latch and the associated pawl is different for each model of vehicles, in order to achieve said positioning of the “S point”.
    Type: Application
    Filed: December 5, 2008
    Publication date: February 24, 2011
    Applicant: VALEO SECURITE HABITACLE
    Inventors: Jean-Marie Lefebvre, Francois Bernier, Laurent Duriez, Patrick Dupont
  • Publication number: 20060241038
    Abstract: The present invention provides a pharmaceutical composition comprising at least one member selected from a compound capable of enhancing A?37 production, a compound capable of inhibiting A?40 and A?42 production and enhancing A?37 production, and salts of the compounds and hydrates thereof.
    Type: Application
    Filed: April 20, 2005
    Publication date: October 26, 2006
    Applicant: Eisai Co., Ltd.
    Inventors: Hideki Watanabe, Francois Bernier, Takehiko Miyagawa